CN104784817A - Physical-chemical reaction direct-current treatment patch - Google Patents
Physical-chemical reaction direct-current treatment patch Download PDFInfo
- Publication number
- CN104784817A CN104784817A CN201510183618.0A CN201510183618A CN104784817A CN 104784817 A CN104784817 A CN 104784817A CN 201510183618 A CN201510183618 A CN 201510183618A CN 104784817 A CN104784817 A CN 104784817A
- Authority
- CN
- China
- Prior art keywords
- class
- physical
- chemical reaction
- treatment
- conductive electrode
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to an auxiliary medical instrument, in particular to a physical-chemical reaction direct-current treatment patch. The physical-chemical reaction direct-current treatment patch comprises an electrolytic medium layer, an active conductive electrode sheet B and an inactive conductive electrode A sheet are arranged on the electrolytic medium layer at interval. The physical-chemical reaction direct-current treatment patch is applicable to auxiliary treatment ofhypertension, hyperplasia of mammary glands, heart or vascular disease, diabetes or hyperglycemia, prostate diseases, arthralgia or rheumatalgia and fatty liver diseases and the like. The physical-chemical reaction direct-current treatment patch is simple in structure, free of power source and disposable.
Description
technical field
The present invention relates to a kind of auxiliary medical apparatus, namely physical and chemical reaction DC treatment pastes.
Background technology
In the prior art, tradition " theory of Chinese medical science " " dialectical theory of TCM Zang-fu " confirms, 361 acupuncture points of human body on 14 primary meridians, are associated with internal organs of the body by meridians, is again the position point that organ disease reacts on body surface simultaneously.Acupuncture point district distinctively on human body has bioactive point, the state of human internal organs by the transmission of meridians, on the zone properties of final body present acupuncture point.Equally, outside stimulation regulates also by meridians effect and organ.DC current by galvanism, is acted on focal zone or acupuncture point district by the present invention, makes it series of biologic state response occurs, and by meridians indirect regulation body or organ dysfunction or state, reaches the object for the treatment of.
Chinese invention patent application description discloses a kind of name on October 10th, 2012 and is called " Bioelectric patch " patent of invention, number of patent application is CN201210229582.1, it be included in insulation fit on stick the conductive electrode at two intervals, its shortcoming could not be electric energy and effect and human body, affects the treatment.
Summary of the invention
The object of this invention is to provide a kind of without the need to power supply, the electrode of two kinds of conductive materials of different qualities and electrolytes medium is utilized to carry out redox reaction, and form loop generation current by two conductive electrode contacts with human body skin, flowed through by electric current and to be correlated with focal area (or acupuncture point district) in human body, the physical and chemical reaction DC treatment carrying out disease treatment pastes.
Technical solution of the present invention is: physical and chemical reaction DC treatment pastes: comprise electrolytic medium layer, the conductive electrode film B of spaced active characteristic on electrolytic medium layer, the conductive electrode film A of torpescence characteristic.The conductive electrode pole piece B of active characteristic is aluminum class or zinc metalloid pole, and the conductive electrode film A of torpescence characteristic is copper class, silver-colored class or carbon class conductive electrode; Or aluminum class and silver-colored class, aluminum class and copper class, zinc class and copper class, zinc class and silver-colored class, ferrum class and copper class, ferrum class and silver-colored class, stannum class and copper class, stannum class and silver-colored class combine.
Withdrawable plastic partition absciss layer (PVC etc.) is had between the conductive electrode film B of the conductive electrode film A of torpescence characteristic and active characteristic and electrolytic medium layer, during for preventing from not using, two electrode slices and electrolyte self produce chemical reaction, exhaust two electrode material characteristics.
The composition of electrolytic medium layer contains with the liquid of human non-toxic and semi liquid state is sour, bases reacting substance.
Electrolytic medium layer is citric acid or the sodium bicarbonate of food stage, is mixed into soft colloidal layer in proportion with water and medical gel.Soft colloidal layer accounts for 55% containing the water of citric acid or sodium bicarbonate; Medical gel accounts for 45%.
Indication: the auxiliary treatment of hypertension, cyclomastopathy, heart or angiopathy, diabetes or hyperglycemia, prostatosis, arthralgia or the disease such as rheumatalgia, fatty liver.
The conductive electrode pole piece B of active characteristic is aluminum class or zinc metalloid pole (as aluminium foil, zinc paper tinsel), and the conductive electrode film A of torpescence characteristic is copper class, silver-colored class, carbon class (as Copper Foil, Yin Bu, graphite flake, carbon plate).And, or aluminum class and silver-colored class, aluminum and copper class, zinc class and copper class, zinc class and silver-colored class, ferrum class and copper class, ferrum class and silver-colored class, stannum class and copper class, stannum class and silver-colored class etc. combine (being not limited thereto).
Two electrode design are active characteristic conductance pole piece (hereinafter referred to as active electrode slice) and torpescence characteristic conductance pole piece (hereinafter referred to as torpescence electrode slice) combined benefit: the conductive electrode film of two different qualities can produce redox reaction in the electrolyte, and the own material behavior difference of active electrode slice and torpescence electrode slice is larger, the voltage difference produced after reacting with electrolyte redox is larger, to be more conducive to therapeutic effect.
Dielectric substrate contains acid or bases characteristic.The effect increasing dielectric substrate is that chemical energy is electric energy the most at last because two conductive electrodes of different qualities must have electrolyte redox reaction could occur.
In the present invention, (active with two or more different qualities, torpescence) conductive electrode film (can be simple metal class, metallization dry goods, metallization stationery, metallized film class, carbon or graphite-like), contact (can be adhesion, immerse, crimping etc.) in electrolyte medium (with the liquid of human non-toxic and semi liquid state acid, bases etc., such as: food stage citric acid, sodium bicarbonate etc.) in, the redox reaction constantly occurred between conductive electrode film and electrolyte by two, and form loop with human body, converts chemical energy is made to be electric energy and effect and human body, namely DC current chemical energy conversion produced of passive form is finally realized, flow through the relative focal area of human body (or inside and outside the point of acupuncture point point-to-point transmission), carry out disease treatment.
Mechanism and inventive point: galvanism imports unidirectional current into human body with the method for disease therapy by electrode.Human body is a complicated conductor, and its physics caused in the tissue, chemical change is depended in the effect of unidirectional current to human body.Under the impact of DC current, in body, carry out electrolysis, electrophoresis, electric osmose change; Ion concentration, protein, permeability of cell membrane, acetylcholine esterase, pH value etc. simultaneously in body all change under the effect of electric current.Its series of biologic state response occurred, can indirect regulation body or organ shape function or state, reaches the object for the treatment of.Galvanism can blood vessel dilating, promotes local blood circulation, improves the nutrition and metabolism of local, adjustment nervous function etc.Meanwhile, under unidirectional current effect, owing to there is a series of biological physics and chemistry variation in body, thus cause body or the corresponding physiological reaction of organ.Pass through produced physiological reaction, also improve pathophysiological process, to reach the effect of disease therapy.
Application site:
Hypertension is attached to (umbilicus) place, SHENJUE acupoint position or tremulous pulse place, neck left and right.Heart disease is attached to place of heart district.Diabetes are attached to middle or Pancreatic Region in the middle part of back.Cyclomastopathy is attached to breast surface (avoiding the hypertrophy position of nipple).Prostatosis is attached to hypogastric region place (bladder location).Fatty liver is attached to hepatic region place.Arthralgia, rheumatalgia are attached to the position of pain.More than more than can pasting with subsides or one according to practical situation note.
On using method 1(not allergic skin-direct note skin): open packaging, take out treatment and paste, before using, extract PVC isolating membrane out; Tear the protection sheet of two block protection paper above two electrodes and two electrode perimeter; Electrode surface is posted in treatment and is directly posted on focal zone.
Using method 2(allergic skin-be attached to garment interior): open packaging, take out treatment and paste, before using, extract PVC isolating membrane out; Tear the two block protection paper (protection sheet of two electrode outer rings does not tear) outside two electrode surfaces; Then after tearing whole protection sheet of electrodeless of another side, this face is attached to focal zone or garment interior corresponding to acupuncture point point, the corresponding skin in focal zone of electrode surface is posted in treatment.Pledge clothes human body skin time, treatment paste two electrodes namely can treat with contact human skin.
Using method 3(women-curing mammary gland hyperplasia): open packaging, take out treatment and paste, before using, extract PVC isolating membrane out; Tear the two block protection paper (protection sheet of two electrode outer rings does not tear) outside two electrode surfaces; Treatment be placed with between medicated bra and breast, the sufferer skin place being now pressed in breast by medicated bra is pasted in treatment, has electrode surface corresponding to focal zone skin.
Use suggestion: use first, suggestion using method 1(draws the method best results).As there is skin pruritus, the general malaise symptoms such as red in therapeutic process, then make using method 2 again into and treat.
The course for the treatment of: every note suggestion laminating 6-8 hour.Time-out suggestion is changed in time.It within every 2 weeks, is a course for the treatment of.
For ensureing curative effect, this treatment note note is longer with the time, and every note is 6-8 hour.Therefore by the action current of every note, 0.2nA-500 μ A/cm is set in
2.Through a large amount of clinical verifications, reach required safe, gradually slow stable therapeutic effect.
Advantage of the present invention is: 1, structure simple, without the need to power supply, single use.2, volume frivolous (thickness < 1.5mm), do not affect wearing, cost is low, can significantly for user alleviates medical expense, easy to use, is convenient to accept.3, electrode, electrolyte are food stage and environment-friendly materials, harmless to human non-toxic, disposable free from environmental pollution with rear garbage.4, make use of different materials cleverly, redox reaction in the electrolyte produces DC voltage, and electric current is flowed through to be correlated with focal area (or acupuncture point district) in human body, carry out the mode of disease treatment, paste use through the Disease such as hypertension, heart disease, property subsides once a day can take effect for 6-8 hour for three days on end afterwards, use 2 weeks, successful, is conducive to the auxiliary treatment subsides use of hypertension, cardio-cerebrovascular diseases patient.
Below in conjunction with accompanying drawing, embodiments of the present invention are described in further detail.
Accompanying drawing explanation
Fig. 1 is structure diagram of the present invention.
Fig. 2 is second embodiment of the invention structure diagram.
Fig. 3-1 is validation test method structure diagram of the present invention.
Fig. 3-2 is another structure diagrams of validation test method of the present invention.
Fig. 4 is Fig. 1 plan structure sketch.
Detailed description of the invention
See Fig. 1,2,3-1,3-2,4, parts title is as follows: electrolytic medium layer 1, the conductive electrode film B of active characteristic, the conductive electrode film A of torpescence characteristic, sealing coat 2, nonwoven layer 3.
See Fig. 1,2,4, physical and chemical reaction DC treatment pastes, and comprises nonwoven layer 3, electrolytic medium layer 1, the conductive electrode film B of spaced active characteristic on electrolytic medium layer 1, the conductive electrode film A of torpescence characteristic, (round or rectangle etc.).Electrolytic medium layer 1 and the conductive electrode film B of active characteristic, have withdrawable PVC sealing coat 2 between the conductive electrode film A of torpescence characteristic.(in actual product application, the chemical reaction of electrode and electrolyte self during for preventing from not using, exhaust material behavior, structural design have employed by the conductive electrode film B of active characteristic, the conductive electrode film A of torpescence characteristic before not using, with electrolyte carry out every
From design framework.Before using, take out sealing coat 2, two electrode A, B are contacted with electrolyte and starts to carry out chemistry redox reaction).
Electrolytic medium layer 1 contains and the liquid of human non-toxic and semi liquid state acid, alkali, salt etc., such as: organic acid, fruit acid, sodium carbonate, sodium bicarbonate etc.Conventional is food stage citric acid or sodium bicarbonate.Soft colloidal layer is mixed in proportion with water and medical gel.Soft colloidal layer accounts for 55% containing the water of citric acid or sodium bicarbonate; Medical gel accounts for 45%.
The conductive electrode pole piece B of active characteristic is aluminum class or zinc class (as aluminium foil, zinc paper tinsel), and the conductive electrode film A of torpescence characteristic is copper class, silver-colored class or graphite-like (as Copper Foil, Yin Bu, graphite flake, carbon plate).And, or aluminum class and silver-colored class, zinc class and copper class, zinc class and silver-colored class, ferrum class and copper class, ferrum class and silver-colored class, stannum class and copper class, stannum class and silver-colored class etc.
Physical features verification method (electrode fitted electrolyte):
1, in the connecting test by checking method of testing Fig. 3-1, voltmeter contact connects active characteristic conductance pole piece B and torpescence characteristic conductance electrode slice A respectively, voltmeter display reading, at about 400-1000mV, proves that the chemistry redox reaction between two electrodes makes it point-to-point transmission and creates DC voltage difference.
In the connecting test of 2, validation test method Fig. 3-2, with high-precision current table nA shelves, treatment subsides A electrode is shown one end with nA and is connected, and nA shows the other end
dreliably be connected on human acupoint point (or region point), the B electrode that treatment is pasted reliably is connected to human acupoint point outer (or another point of region point)
con.Namely C, D in Fig. 3-2 2 and human skin's reliable contacts.2, now, nA meter reading is between 0.1nA-800 μ A.(product classification is different, and human body actual state determines).3, demonstrate electric current and flow through human body this acupuncture point point or focal area.
Experimental example 1
Physical and chemical reaction DC treatment pastes treatment hypertension clinical effect trial situation statistics:
1, case selection: hyperpietic 35 example, wherein male 20 example, women 15 example, the age 35-65 year between, the most of patients course of disease is more than half a year.
2, Therapeutic Method: physical and chemical reaction DC treatment pastes, and is affixed on umbilicus place or tremulous pulse place, neck left and right.Once-a-day, one time 8 hours 7 days is a course for the treatment of, treats 2 courses for the treatment of.
3, curative effect judging standard:
Efficacy evaluation is carried out with reference to efficacy of antihypertensive treatment evaluation criteria in " new Chinese medicine guideline of clinical investigations ".
Effective: diastolic pressure decline 1.3kpa, and reach normal range; Though diastolic pressure is not down to normally, decline 2.7kpa or following.Wherein one must be possessed.Blood pressure is basicly stable.
Effective: diastolic pressure declines not as good as 1.3kpa, but reaches normal range; Diastolic pressure comparatively treats front decline 1.3-2.5kpa, but does not reach normal range; Systolic pressure comparatively treats front more than decline 4.0kpa.Wherein one must be possessed.Clinical symptoms is obviously alleviated.
Invalid: not reach above standard person.Clinical symptoms is not improved.
4, therapeutic outcome:
| The state of an illness | Number | Effective | Effectively | Invalid | Total effective rate % |
| Hypertension | 35 | 30 | 5 | 0 | 100 |
Added up from above-mentioned clinical efficacy situation: obvious effective rate 86%, effective percentage 14%, total effective rate is 100%.Physical and chemical reaction DC treatment pastes has remarkable auxiliary curative effect to high blood pressure disease, adheres to life-time service.
Experimental example 2
Physical and chemical reaction DC treatment pastes treatment cyclomastopathy clinical efficacy situation statistics:
1, case statistics: cyclomastopathy patient 41 example, the age, the course of disease was-4 years half a year in 31-50 one full year of life.
2, Therapeutic Method: the pressing of cyclomastopathy physical and chemical reaction DC treatment is attached to patient's cyclomastopathy position, pastes every day, often pastes use 6 hours, within 7 days, is a course for the treatment of, treats 2 courses for the treatment of.
3, curative effect judging standard:
Effective: hypertrophy major part disappears, not pain, not distending pain.Mammary gland is firmly tough, the most of disappearance of thickened areas.
Effective: hypertrophy obviously disappears, pain, distending pain obviously alleviate.Mammary gland is firmly tough, thickened areas reduces, matter is soft.
Invalid: hypertrophy does not change or change not obvious, pain, distending pain do not alleviate or alleviate not obvious, without improving.
4, therapeutic outcome:
| The state of an illness | Number | Effective | Effectively | Invalid | Total effective rate % |
| Cyclomastopathy | 41 | 31 | 10 | 0 | 100 |
Clinical Practice proves: cyclomastopathy physical and chemical reaction DC treatment pastes to have removes the effect such as mastalgia, softening hypertrophy.Obvious effective rate 76%, effective percentage 24%, total effective rate is 100%.
Experimental example 3
Physical and chemical reaction DC treatment pastes treatment heart or angiopathy clinical efficacy situation statistics:
1, case statistics: heart or angiopathy case 45 example, the age, the course of disease was-6 years Mays in 40-55 one full year of life.
2, Therapeutic Method: physical and chemical reaction DC treatment is attached to position, patient's heart district, pastes every day, often pastes use 8 hours, within 7 days, is a course for the treatment of, treats 2 courses for the treatment of.
3, curative effect judging standard:
Effective: symptom and arrhythmia obviously alleviate, and the lab testings such as electrocardiogram obviously improve.
Effective: symptom alleviates or the intermittent time of showing effect extends, and lab testing is improved.
Invalid: symptom and arrhythmia unchanged.
4, therapeutic outcome:
| The state of an illness | Number | Effective | Effectively | Invalid | Total effective rate % |
| Heart or angiopathy | 45 | 27 | 18 | 0 | 100 |
Clinical Practice proves: physical and chemical reaction DC treatment pastes to have and promotes that the rhythm of the heart normally acts on.Obvious effective rate 58%, effective percentage 42%, total effective rate is 100%.
Experimental example 4
Physical and chemical reaction DC treatment pastes treatment diabetes or hyperglycemic disorder clinical efficacy situation statistics:
1, case selection: diabetic patients person 55 example, wherein male 35 example, women 20 example, the age 40-60 year.
2, Therapeutic Method: physical and chemical reaction DC treatment is attached to middle or Pancreatic Region in the middle part of back.Once-a-day, one time 8 hours 7 days is a course for the treatment of, pastes with 5 courses for the treatment of.
3, curative effect judging standard:
Effective: blood glucose and urine sugar value obviously reduce.
Effective: blood glucose and urine sugar value all have reduction.
Invalid: blood glucose and urine sugar value change are not quite.
4, therapeutic outcome:
| The state of an illness | Number | Effective | Effectively | Invalid | Total effective rate % |
| Diabetes | 55 | 44 | 11 | 0 | 100 |
Clinical Practice proves: physical and chemical reaction DC treatment pastes has blood sugar reducing function.Obvious effective rate 80%, effective percentage 20%, total effective rate is 100%.
Experimental example 5
Physical and chemical reaction DC treatment pastes treatment prostatosis clinical efficacy situation statistics:
1, case statistics: prostate case 60 example, the age, the course of disease was-4 years half a year in 30-50 one full year of life.
2, Therapeutic Method: physical and chemical reaction DC treatment is attached to hypogastric region (bladder) position, pastes every day, often pastes use 7 hours, within 7 days, is a course for the treatment of, treats 2 courses for the treatment of.
3, curative effect judging standard:
Effective: unobstructed micturition, prostatic examination is obviously reduced, and residual urine obviously reduces.
Effective: symptom of urinating takes a turn for the better, residual urine reduces.
Invalid: symptom and every inspection are all without improvement.
4, therapeutic outcome:
| The state of an illness | Number | Effective | Effectively | Invalid | Total effective rate % |
| Prostate | 60 | 42 | 18 | 0 | 100 |
Clinical Practice proves: physical and chemical reaction DC treatment pastes to have to be beneficial to urinates, and reduces pain effect.Obvious effective rate 70%, effective percentage 30%, total effective rate is 100%.
Experimental example 6
Physical and chemical reaction DC treatment pastes treatment joint and rheumatalgia clinical efficacy situation statistics:
1, case selection: arthralgia patient 31 example, wherein male 20 example, women 11 example, the age 27-60 year.
2, Therapeutic Method: the joint or the rheumatism position that physical and chemical reaction DC treatment are attached to pain, once-a-day, one time 7 hours 7 days is a course for the treatment of, treats 3 courses for the treatment of.
3, curative effect judging standard:
Effective: swollen, pain disappears substantially, and joint, each position obviously improves.
Effective: swollen, pain obviously alleviates, joint, each position is seen and is made moderate progress.
Invalid: as before, joint, each position is with before treatment for swollen, pain.
4, therapeutic outcome:
| The state of an illness | Number | Effective | Effectively | Invalid | Total effective rate % |
| Joint or rheumatalgia | 31 | 23 | 8 | 0 | 100 |
Clinical Practice proves: physical and chemical reaction DC treatment pastes has alleviating pain effect.Obvious effective rate 74%, effective percentage 26%, total effective rate is 100%.
Experimental example 7
Physical and chemical reaction DC treatment pastes treatment fatty liver clinical efficacy situation statistics:
1, case selection: Patients with Fatty Liver 38 example, wherein male 28 example, women 10 example, the age 27-45 year.
2, Therapeutic Method: physical and chemical reaction DC treatment is attached to position, hepatic region, once-a-day, one time 7 hours 7 days is a course for the treatment of, treats 5 courses for the treatment of.
3, curative effect judging standard:
1, effective: the main clinic symptoms such as patient's hepatic insufficiency, fatigue and weak disappears, and muscle power is obviously recovered, liver function also be improved significantly.
2, effective: clinical symptom relief, liver function improves.
3, invalid: the symptom of patient, sign, liver function are all not improved.
4, therapeutic outcome:
| The state of an illness | Number | Effective | Effectively | Invalid | Total effective rate % |
| Fatty liver | 38 | 25 | 13 | 0 | 100 |
Clinical Practice proves: physical and chemical reaction DC treatment pastes the auxiliary treatment to Patients with Fatty Liver, has obvious effect.Obvious effective rate 66%, effective percentage 34%, total effective rate is 100%.
Describe above, just the specific embodiment of the present invention, various illustrating is not construed as limiting flesh and blood of the present invention.
Claims (7)
1. a physical and chemical reaction DC treatment pastes, and it is characterized in that comprising electrolytic medium layer (1), the conductive electrode film B of the upper spaced active characteristic of electrolytic medium layer (1), the conductive electrode film A of torpescence characteristic.
2. paste according to physical and chemical reaction DC treatment according to claim 1, it is characterized in that the conductive electrode film A of torpescence characteristic and between the conductive electrode film B of active characteristic and electrolytic medium layer (1), have withdrawable plastic partition absciss layer (2).
3. paste according to the physical and chemical reaction DC treatment described in claim 1 or 2, it is characterized in that the composition of electrolytic medium layer (1) contains with the liquid of human non-toxic and semi liquid state is sour, bases reacting substance.
4. paste according to physical and chemical reaction DC treatment according to claim 3, it is characterized in that citric acid that electrolytic medium layer (1) is food stage or sodium bicarbonate, be mixed into soft colloidal layer with water and medical gel in proportion.
5. paste according to physical and chemical reaction DC treatment according to claim 4, it is characterized in that soft colloidal layer accounts for 55% containing the water of citric acid or sodium bicarbonate; Medical gel accounts for 45%.
6. paste according to physical and chemical reaction DC treatment according to claim 1, it is characterized in that the conductive electrode pole piece B of active characteristic is aluminum class or zinc metalloid pole, the conductive electrode film A of torpescence characteristic is copper class, silver-colored class or carbon class conductive electrode; Or aluminum class and silver-colored class, aluminum class and copper class, zinc class and copper class, zinc class and silver-colored class, ferrum class and copper class, ferrum class and silver-colored class, stannum class and copper class, stannum class and silver-colored class combine.
7. paste according to physical and chemical reaction DC treatment according to claim 1, it is characterized in that being used for the treatment of hypertension, cyclomastopathy, heart disease, diabetes, prostatosis, rheumatalgia or fatty liver.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510183618.0A CN104784817A (en) | 2015-04-19 | 2015-04-19 | Physical-chemical reaction direct-current treatment patch |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510183618.0A CN104784817A (en) | 2015-04-19 | 2015-04-19 | Physical-chemical reaction direct-current treatment patch |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104784817A true CN104784817A (en) | 2015-07-22 |
Family
ID=53550288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510183618.0A Pending CN104784817A (en) | 2015-04-19 | 2015-04-19 | Physical-chemical reaction direct-current treatment patch |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104784817A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040267190A1 (en) * | 2003-06-02 | 2004-12-30 | Dov Tamarkin | Kit, device and method for controlled delivery of oxidizing agent into the skin |
| CN1607970A (en) * | 2001-10-24 | 2005-04-20 | 纸型电池有限公司 | Dermal patch |
| CN102711905A (en) * | 2009-11-13 | 2012-10-03 | 强生消费者公司 | Galvanic skin treatment device |
| CN104147694A (en) * | 2003-06-30 | 2014-11-19 | 强生消费者公司 | Device for treating human or animal barrier film |
| CN204563308U (en) * | 2015-04-19 | 2015-08-19 | 通化市佳俊生物电子有限公司 | Physical and chemical reaction DC treatment pastes |
-
2015
- 2015-04-19 CN CN201510183618.0A patent/CN104784817A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1607970A (en) * | 2001-10-24 | 2005-04-20 | 纸型电池有限公司 | Dermal patch |
| US20040267190A1 (en) * | 2003-06-02 | 2004-12-30 | Dov Tamarkin | Kit, device and method for controlled delivery of oxidizing agent into the skin |
| CN104147694A (en) * | 2003-06-30 | 2014-11-19 | 强生消费者公司 | Device for treating human or animal barrier film |
| CN102711905A (en) * | 2009-11-13 | 2012-10-03 | 强生消费者公司 | Galvanic skin treatment device |
| CN204563308U (en) * | 2015-04-19 | 2015-08-19 | 通化市佳俊生物电子有限公司 | Physical and chemical reaction DC treatment pastes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ABRAMSON et al. | Skin reactions: XII. Patterns produced in the skin by electrophoresis of dyes | |
| CN204563308U (en) | Physical and chemical reaction DC treatment pastes | |
| CN206228767U (en) | Nerve electrode and preparation method thereof | |
| CN104162228A (en) | Pulse signal output method, pulse signal instrument, application of pulse signal instrument and prostate treatment instrument | |
| CN205055197U (en) | Biological electrotherapy appearance of multi -functional negative pressure | |
| CN204502126U (en) | A kind of multifunctional prostate recovery therapeutic equipment | |
| CN216725523U (en) | Blood sugar control device of percutaneous electrostimulation | |
| CN104784817A (en) | Physical-chemical reaction direct-current treatment patch | |
| CN101274118B (en) | Physiotherapy electrode plate clamping self-pasting medicine carrying membrane and manufacture method thereof | |
| CN105268098A (en) | Foot-bathing device having function of electrotherapy | |
| CN104759026A (en) | Release type electric potential balance treatment patch | |
| CN202637710U (en) | Biological electric plaster | |
| CN202892661U (en) | Bioelectric regulation instrument | |
| CN104922791B (en) | Non-invasive acupuncture patch and preparation method thereof | |
| CN100525751C (en) | Meridian point therapeutic plaster of high polymer multi hole energy gathering ion and its preparation method and application | |
| CN204563307U (en) | The treatment of release type potential balance is pasted | |
| CN203315555U (en) | Body-electricity meridian and collateral conditioning instrument | |
| CN101496931A (en) | Low-potential negative ion health-care physical therapy method and system | |
| CN101502700A (en) | Low-potential direct current negative electricity introduction method and system for patient body | |
| JPH08317998A (en) | Therapeutic apparatus with many effects | |
| RU2474411C1 (en) | Method of treating patients with diabetic angiopathy of lower extremities | |
| CN201361364Y (en) | Therapeutic electrode for electrotherapy apparatus | |
| CN102716548A (en) | Bioelectric patch | |
| CN201609549U (en) | Therapy special electrode for andropathy electric needle | |
| CN212756839U (en) | Special electrode slice for pelvic cavity electrical stimulation physiotherapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150722 |